慢性阻塞性肺疾病合并肺结核临床治疗效果及抗结核药物的不良反应分析

Analysis of Clinical Therapeutic Effect and Adverse Reaction of Antituberculosis Drugs in Patients with Chronic Obstructive Pulmonary Disease Complicated with Pulmonary Tuberculosis

分析了慢性阻塞性肺疾病合并肺结核临床治疗效果,探究了造成抗结核药物不良反应的因素。选取2019年—2020年1月期间泰安市肿瘤防治院收治的200例慢性阻塞性肺疾病合并肺结核患者为研究对象,对选取患者进行数据分析,对抗结核药物的临床实际治疗效果以及造成患者出现抗结核药物不良反应的因素进行归纳。研究发现,在临床治疗期间,对慢性阻塞性肺疾病合并肺结核患者应用抗结核药物,会发生程度不同的不良反应。根据调查结果显示,患者个体的肝病史、治疗类型、诊断类型是导致不良反应的主要因素。

To explore and analyze the clinical therapeutic effect of chronic obstructive pulmonary disease(COPD)with pulmonary tuberculosis(TB)and the factors influencing the adverse reactions of anti TB drugs.200 patients with chronic obstructive pulmonary disease(COPD)and pulmonary tuberculosis(TB)from 2019 to January 2020 were selected as the research objects,and the data of the selected patients were summarized and analyzed.The actual clinical treatment effect of anti TB drugs and the factors causing adverse reactions of anti TB drugs were summarized and analyzed.The study found that the use of antituberculosis drugs in patients with chronic obstructive pulmonary disease(COPD)and pulmonary tuberculosis(TB)during clinical treatment will lead to adverse reactions of varying degrees.According to the survey results,the history of individual liver disease,treatment type and diagnosis type are the main factors leading to adverse reactions.